Johns Hopkins ABX Guide
Cycloserine
INDICATIONS
FDA
FDA
- Second-line tuberculosis treatment [combine w/ other antitubercular agents for failure of primary medications (e.g., pyrazinamide, isoniazid, rifampin, ethambutol +/- streptomycin)].
- Treatment of acute urinary tract infection treatment caused by Enterobacter spp. and Escherichia coli (generally not recommended) .
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 19, 2017
Citation
Pham, Paul A, and John G Bartlett. "Cycloserine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540149/all/Cycloserine.
Pham PA, Bartlett JG. Cycloserine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540149/all/Cycloserine. Accessed September 8, 2024.
Pham, P. A., & Bartlett, J. G. (2017). Cycloserine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540149/all/Cycloserine
Pham PA, Bartlett JG. Cycloserine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2024 September 08]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540149/all/Cycloserine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cycloserine
ID - 540149
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
Y1 - 2017/03/19/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540149/all/Cycloserine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
